Literature DB >> 19240157

Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors.

Raymond S Douglas1, Thomas H Brix, Catherine J Hwang, Laszlo Hegedüs, Terry J Smith.   

Abstract

CONTEXT: Graves' disease (GD) is an autoimmune process of the thyroid and orbital connective tissues. The fraction of T and B cells expressing IGF-I receptor (IGF-IR) is increased in GD. It is a potentially important autoantigen in GD. Susceptibility to GD arises from both genetic and acquired factors.
OBJECTIVE: The aim of the study was to determine whether the increased frequency of IGF-IR-expressing T and B cells in GD results from genetic or nongenetic factors. DESIGN/SETTING/PARTICIPANTS: Display of IGF-IR was assessed on blood lymphocytes from 18 pairs of monozygotic twins in the Danish Twin Registry, including seven discordant pairs, four pairs concordant for GD, and seven healthy pairs. MAIN OUTCOME MEASURES: Subjects underwent physical examination and laboratory analysis. Surface display of IGF-IR on T and B cells was analyzed by flow cytometry.
RESULTS: Twins with GD display increased IGF-IR-expressing CD3(+) T cells and T cell subsets including total CD4(+), CD4(+) naive, CD4(+) memory, and CD8(+) cells (P < 0.0001, P = 0.0001, P = 0.0003, P = 0.01, and P = 0.02, respectively) compared to healthy twins. The frequency of IGF-IR-expressing B cells from affected twins was increased relative to healthy controls (P = 0.009). In pairs discordant for GD, affected twins exhibited increased frequency of IGF-IR(+) CD3(+), CD4(+), and CD4(+) naive T cells (P < 0.05, P = 0.03, and P = 0.03, respectively) compared to their healthy twin.
CONCLUSION: Our findings suggest that more frequent IGF-IR(+) T cells in GD cannot be attributed to genetic determinants. Rather, this skew appears to be acquired. These results underscore the potential role of nongenetic, acquired factors in genetically susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240157      PMCID: PMC2684473          DOI: 10.1210/jc.2008-2810

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease.

Authors:  Xiaoming Yin; Rauf Latif; Yaron Tomer; Terry F Davies
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

3.  Graves' disease.

Authors:  Barry S Levy
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

4.  Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.

Authors:  R Villanueva; A M Inzerillo; Y Tomer; G Barbesino; M Meltzer; E S Concepcion; D A Greenberg; N MacLaren; Z S Sun; D M Zhang; S Tucci; T F Davies
Journal:  Thyroid       Date:  2000-09       Impact factor: 6.568

5.  Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study.

Authors:  T H Brix; P S Hansen; K O Kyvik; L Hegedüs
Journal:  Arch Intern Med       Date:  2000-03-13

6.  Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.

Authors:  Raymond S Douglas; Andrew G Gianoukakis; Shweta Kamat; Terry J Smith
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

7.  Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.

Authors:  Natássia E Bufalo; Roberto B Santos; Adriano N Cury; Renato A Andrade; Joseane Morari; Elaine C Morari; Janaína L Leite; Osmar Monte; João H Romaldini; Laura S Ward
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

8.  Skewed X-chromosome inactivation in scleroderma.

Authors:  Elif Uz; Laurence S Loubiere; Vijayakrishna K Gadi; Zeynep Ozbalkan; Jeffrey Stewart; J Lee Nelson; Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

Authors:  Raymond S Douglas; Vibharavi Naik; Catherine J Hwang; Nikoo F Afifiyan; Andrew G Gianoukakis; Daniel Sand; Shweta Kamat; Terry J Smith
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 10.  Environmental tobacco smoke exposure and eye disease.

Authors:  N Lois; E Abdelkader; K Reglitz; C Garden; J G Ayres
Journal:  Br J Ophthalmol       Date:  2008-07-25       Impact factor: 4.638

View more
  6 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 2.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 3.  Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Authors:  Terry J Smith; Laszlo Hegedüs; Raymond S Douglas
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

Review 4.  Pathogenesis of Graves' orbitopathy: a 2010 update.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

5.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27

Review 6.  Insulin-Like Growth Factor Pathway and the Thyroid.

Authors:  Terry J Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.